grapefruit
Selected indexed studies
- Grapefruit-medication interactions: forbidden fruit or avoidable consequences? (CMAJ, 2013) [PMID:23184849]
- Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. (Nat Commun, 2013) [PMID:23695661]
- Grapefruit-drug interactions. (Drugs, 2010) [PMID:21142260]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Grapefruit-medication interactions: forbidden fruit or avoidable consequences? (2013) pubmed
- Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. (2013) pubmed
- Grapefruit-drug interactions. (2010) pubmed
- Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review. (2018) pubmed
- Grapefruit-drug interactions. (2007) pubmed
- Anti-Biofilm Activity of Grapefruit Seed Extract against Staphylococcus aureus and Escherichia coli. (2019) pubmed
- Grapefruit Seed Extract-Added Functional Films and Coating for Active Packaging Applications: A Review. (2023) pubmed
- Grapefruit and its biomedical, antigenotoxic and chemopreventive properties. (2018) pubmed
- Grapefruit: the last decade acquisitions. (2000) pubmed
- Attention--grapefruit! (2009) pubmed